These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2949058

  • 1. Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats.
    Sommerfelt L, Hauge ER, Ursin R.
    J Neural Transm; 1987; 68(1-2):127-44. PubMed ID: 2949058
    [Abstract] [Full Text] [Related]

  • 2. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R, Bjorvatn B, Sommerfelt L, Underland G.
    Behav Brain Res; 1989 Aug 01; 34(1-2):117-30. PubMed ID: 2527519
    [Abstract] [Full Text] [Related]

  • 3. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1987 Apr 01; 24(1):1-10. PubMed ID: 2953350
    [Abstract] [Full Text] [Related]

  • 4. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1991 Nov 26; 45(2):105-15. PubMed ID: 1838688
    [Abstract] [Full Text] [Related]

  • 5. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B, Ursin R.
    Behav Brain Res; 1990 Nov 30; 40(3):239-46. PubMed ID: 2149499
    [Abstract] [Full Text] [Related]

  • 6. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B, Bjørkum AA, Neckelmann D, Ursin R.
    Sleep; 1995 Jul 30; 18(6):451-62. PubMed ID: 7481417
    [Abstract] [Full Text] [Related]

  • 7. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L, Ursin R.
    Sleep; 1993 Jan 30; 16(1):15-22. PubMed ID: 8456229
    [Abstract] [Full Text] [Related]

  • 8. Sleep-wake and eeg effects following adenosine a1 agonism and antagonism: similarities and interactions with sleep-wake and eeg effects following a serotonin reuptake inhibitor in rats.
    Ursin R, Bjorvatn B.
    Sleep Res Online; 1998 Jan 30; 1(3):119-27. PubMed ID: 11382868
    [Abstract] [Full Text] [Related]

  • 9. Chronic zimeldine administration to cats: sustained increase of serotonergic effect as measured with sleep parameters.
    Sommerfelt L.
    Pharmacol Toxicol; 1990 Feb 30; 66(2):128-32. PubMed ID: 2138291
    [Abstract] [Full Text] [Related]

  • 10. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H, Burki HR.
    Neuropsychobiology; 1987 Feb 30; 17(4):206-12. PubMed ID: 2964564
    [Abstract] [Full Text] [Related]

  • 11. The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats.
    Bjorvatn B, Neckelmann D, Ursin R.
    Pharmacol Biochem Behav; 1992 May 30; 42(1):49-56. PubMed ID: 1388278
    [Abstract] [Full Text] [Related]

  • 12. Lesion of descending 5-HT pathways increases zimeldine-induced waking in rats.
    Bjørkum AA, Neckelmann D, Bjorvatn B, Ursin R.
    Physiol Behav; 1995 May 30; 57(5):959-66. PubMed ID: 7610150
    [Abstract] [Full Text] [Related]

  • 13. Studies on sleep/wake effects of serotonin reuptake inhibitors and receptor subtype involvement.
    Ursin R, Bjorvatn B, Sommerfelt L, Neckelmann D, Bjørkum AA.
    J Sleep Res; 1992 Sep 30; 1(3):157-162. PubMed ID: 10607045
    [Abstract] [Full Text] [Related]

  • 14. Role of serotonin in memory: facilitation by alaproclate and zimeldine.
    Altman HJ, Nordy DA, Ogren SO.
    Psychopharmacology (Berl); 1984 Sep 30; 84(4):496-502. PubMed ID: 6241314
    [Abstract] [Full Text] [Related]

  • 15. Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldine.
    Aberg-Wistedt A, Alvariza M, Bertilsson L, Malmgren R, Wachtmeister H.
    Acta Psychiatr Scand; 1985 Mar 30; 71(3):256-68. PubMed ID: 2580422
    [Abstract] [Full Text] [Related]

  • 16. The effect of acute zimeldine and alaproclate administration on the acquisition of two-way active avoidance: comparison with other antidepressant agents, test of selectivity and sub-chronic studies.
    Archer T, Ogren SO, Johansson G, Ross SB.
    Psychopharmacology (Berl); 1984 Mar 30; 84(2):188-95. PubMed ID: 6239299
    [Abstract] [Full Text] [Related]

  • 17. 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man.
    Nicholson AN, Pascoe PA.
    Neuropharmacology; 1986 Oct 30; 25(10):1079-83. PubMed ID: 2946975
    [Abstract] [Full Text] [Related]

  • 18. Diurnal differences in L-tryptophan sleep and temperature effects in the rat.
    Olsen OE, Neckelmann D, Ursin R.
    Behav Brain Res; 1994 Dec 15; 65(2):195-203. PubMed ID: 7718152
    [Abstract] [Full Text] [Related]

  • 19. Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Ogren SO, Holm AC.
    J Neural Transm; 1980 Dec 15; 47(4):253-71. PubMed ID: 6446594
    [Abstract] [Full Text] [Related]

  • 20. Cortical beta- and alpha 2- adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamine.
    Ask AL, Fowler CJ, Hall H, Kelder D, Ross SB, Sääf J.
    Acta Pharmacol Toxicol (Copenh); 1986 Jan 15; 58(1):16-24. PubMed ID: 3006428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.